# Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation

> **NCT04867057** · PHASE1 · COMPLETED · sponsor: **ZYUS Life Sciences Inc.** · enrollment: 41 (actual)

## Conditions studied

- Healthy
- Osteoarthritis

## Interventions

- **DRUG:** Trichomylin for SAD
- **DRUG:** Placebo for SAD
- **DRUG:** Trichomylin for MAD
- **DRUG:** Placebo for MAD

## Key facts

- **NCT ID:** NCT04867057
- **Lead sponsor:** ZYUS Life Sciences Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-19
- **Primary completion:** 2022-02-18
- **Final completion:** 2022-05-30
- **Target enrollment:** 41 (ACTUAL)
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867057

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867057, "Trichomylin® Safety, Tolerability & Pharmacokinetics in Healthy Adults and First in Human Osteoarthritis Pain Evaluation". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04867057. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*